In addition, when using the publicly available R2 microarray analysis and visualization platform with expression array data from 88 neuroblastoma tumors (available at http://r2.amc.nl[21],) EP2 mRNA expression was significantly correlated with poor clinical outcome with highest expression found in MYCN-amplified tumors (data not shown). The gene discussed is MYCN; the disease is neuroblastoma.